An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo
Dong Wan Seo(Dankook University), William G. Stetler‐Stevenson(Center for Cancer Research), Adriana Albini(Istituti di Ricovero e Cura a Carattere Scientifico), Liliana Guédez(National Cancer Institute), W. Carl Saxinger(National Cancer Institute), Anna Rita Cantelmo(Inserm)
Cited by 36
Related Papers
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
|Cancer Cell|2016|660
TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
|Frontiers in Immunology|2023|464
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
|Frontiers in Immunology|2018|400